ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Issues related to patent reform (the America Invents Act (S.23/H.R. 1249))
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CORRIGAN | — |
| MARY LACEY REUTHER New | — |
| MICHAEL RUGGIERO | — |
Medicare/Medicaid MMM
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CORRIGAN | — |
| MARY LACEY REUTHER New | — |
| MICHAEL RUGGIERO | — |
Taxation/Internal Revenue Code TAX
Issues related to the pharmaceutical sales fee (no specific bills) Issues related to the renewal of the R&D tax credit (no specific bills)
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CORRIGAN | — |
| MARY LACEY REUTHER New | — |
| MICHAEL RUGGIERO | — |
Health Issues HCR
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics (no specific bills) Issues related to the supply of medical isotopes (the American Medical Isotopes Production Act (S.99)) Issues related to reauthorization of the Prescription Drug User Fee Act (no specific bills) Issues related to cancer research and treatment (no specific bills) Issues related to drug safety (no specific bills)
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CORRIGAN | — |
| MARY LACEY REUTHER New | — |
| MICHAEL RUGGIERO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.